BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 210104)

  • 1. Histological discrimination of malignancy in mucinous ovarian tumours.
    Blanco AA; Gibbs AC; Langley FA
    Histopathology; 1977 Nov; 1(6):431-43. PubMed ID: 210104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insular carcinoid of ovary associated with malignant mucinous tumors.
    Robboy SJ
    Cancer; 1984 Nov; 54(10):2273-6. PubMed ID: 6091862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian epithelial tumours of borderline malignancy: pathological features and current status.
    Br J Obstet Gynaecol; 1983 Aug; 90(8):743-50. PubMed ID: 6309211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphological prognosis factors in ovarian carcinoma].
    Stegner HE
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):425-30. PubMed ID: 2993093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian tumours: a study of 282 cases.
    Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
    J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances.
    Klemi PJ
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):465-70. PubMed ID: 716907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
    Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
    Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological study of 107 ovarian tumours.
    Muzaffar M; Malik IA; Ashraf S
    J Pak Med Assoc; 1987 Aug; 37(8):194-7. PubMed ID: 2824871
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucinous tumors of the ovary. II. Ultrastructural features of mucinous cystadenocarcinomas.
    Fenoglio CM; Ferenczy A; Richart RM
    Am J Obstet Gynecol; 1976 Aug; 125(7):990-9. PubMed ID: 941955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology.
    Mandai M; Konishi I; Kuroda H; Komatsu T; Yamamoto S; Nanbu K; Matsushita K; Fukumoto M; Yamabe H; Mori T
    Hum Pathol; 1998 Jan; 29(1):34-40. PubMed ID: 9445131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine cells in cystic mucinous tumours of the ovary.
    Louwerens JK; Schaberg A; Bosman FT
    Histopathology; 1983 May; 7(3):389-98. PubMed ID: 6192070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
    Bouzourene H; Genton CY
    Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors.
    Moro F; Zannoni GF; Arciuolo D; Pasciuto T; Amoroso S; Mascilini F; Mainenti S; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):261-270. PubMed ID: 28782867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Hart WR
    Hum Pathol; 1977 Sep; 8(5):541-9. PubMed ID: 903145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1 is expressed in ovarian mucinous neoplasms.
    Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
    Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.
    Fraggetta F; Pelosi G; Cafici A; Scollo P; Nuciforo P; Viale G
    Virchows Arch; 2003 Dec; 443(6):782-6. PubMed ID: 14576939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histogenetic considerations on mucinous cystomas of the ovary based on histochemical and immunohistochemical findings].
    Lapertosa G
    Pathologica; 1989; 81(1074):381-401. PubMed ID: 2696922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.